article thumbnail

470% price increases

World of DTC Marketing

Today, AbbVie charges approximately $77,000 for a year’s supply of Humira—470% more than when the drug was launched in 2003. Today, Imbruvica is priced at $181,529 per year for a patient taking three pills per day, compared to $99,776 per year at launch. net revenue from Humira. The last of these patents is set to expire in 2037.

article thumbnail

The 4 Types of Medtech Innovation  

Cesare Ferrari

In the medical device business, the capacity for innovation is commonly regarded as a key competence and a powerful response mechanism for companies operating in our complex and highly competitive environment. The purpose of this post is to help MedTech professionals to better understand the different types of innovation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amarin Makes Moves towards Global Expansion of Vazkepa

Pharmaceutical Technology

AstraZeneca ’s cholesterol drug Crestor (rosuvastatin) was approved in 2003 in the US but only approved in Germany in 2008. This was a landmark event as Vazkepa was the first FDA-approved drug for use in combination with statin therapies for hypertriglyceridemic patients. Cardiovascular disease landscape.

article thumbnail

The Inflation Reduction Act Passed, Now What?

PM360

Each of these topics would represent sweeping changes on their own, and together, the IRA represents arguably the largest change to prescription drug financing in the United States since the Medicare Modernization Act of 2003, which started the Part D program. Maximum patient Part D out-of-pocket set at $2,000.

article thumbnail

Biosimilars Market Set for Biggest Year Yet in 2023

PM360

Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. Switching patients from brand to biosimilar, as well as between biosimilars, was also highlighted in the survey. pharmaceutical industry. pharmaceutical industry.

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

Will posting rates online actually help patients shop around for the best, most affordable care? He is responsible for positioning the company to provide value to its members, partners, and community through innovative and affordable patient care. The regulation required concrete companies to disclose negotiated prices.

article thumbnail

Healthcare Price Transparency is Here. Now What?

Clarify Health

Will posting rates online actually help patients shop around for the best, most affordable care? He is responsible for positioning the company to provide value to its members, partners, and community through innovative and affordable patient care. The regulation required concrete companies to disclose negotiated prices.